Product ID: SQMIG35H2058
Report ID:
SQMIG35H2058 |
Region:
Global |
Published Date: April, 2024
Pages:
219
|
Tables:
99 |
Figures:
67
North America Expected to Dominate the Market, The biopharmaceuticals market in North America is being driven primarily by the rising incidence of chronic diseases in the United States and rising investments in R&D.In the field of life sciences, the United States has been acknowledged as the global innovation capital.In the early stages of biopharmaceutical companies, it participates in global capital investments. The North American biopharmaceuticals market is anticipated to expand as a result of the increase in COVID-19-related clinical trials.Nearly 1,750 clinical trials for the development of vaccines and drugs for the treatment of COVID-19 were in progress as of January 2021, according to the Pharmaceutical Research and Manufacturers of America. 420 of these clinical trials were based in the United States. Globocan estimates that there will be 2,281,658 new cases of cancer in the United States in 2020.Additionally, 612,390 deaths were recorded. The studied market is driven by the demand for effective therapeutics and the high incidence of cancer.
In Walk 2020, Thermo Fisher Logical Inc. contributed almost USD 475 million to grow its biologics, cell and quality treatment, and medication item improvement offices and increment its worldwide business abilities. In a similar vein, Eli Lilly and Company agreed to acquire Dermira, a biopharmaceutical company, in January 2020.The addition of Dermira's lebrikizumab, an IL-13 antibody intended for the treatment of moderate-to-severe atopic dermatitis, to the company's biopharmaceutical portfolio aided this acquisition.
As a result, the studied market is anticipated to expand significantly in North America over the forecast period due to the aforementioned factors.
Our industry expert will work with you to provide you with customized data in a short amount of time.
REQUEST FREE CUSTOMIZATIONWant to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.
Product ID: SQMIG35H2058